{
  "docId": "019de511-70b9-744d-9fdd-cb0d25e1c298",
  "docSlug": "65af9093c9ec9ca745928fa125179681",
  "documentTitle": "Avantor | Investor Day Presentation Deck | 89 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 89,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "other",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide maps Avantor's product/service categories to the R&D process.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de511-70b9-744d-9fdd-cb0d25e1c298/24",
  "deckHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298",
  "deckJsonHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298.json",
  "deckAnchorHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "R&D PROCESS: Understanding mechanism of disease, Drug target & identification, Biopharmaceutical development, Testing in biochemical & cellular models, Animal & first in man studies",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4f518b0-9ced-47bc-b1ae-47bb533f9c32",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.3,
        "y": 0.5
      },
      "kind": "image",
      "text": "Materials & consumables, Equipment & instrumentation, Services",
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54d458fe-d730-4abd-a2e0-326f393c4702",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.72,
        "w": 0.25,
        "x": 0.04,
        "y": 0.43
      },
      "kind": "image",
      "text": "Scientist working in lab",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0ce23bf-e3af-419b-ac97-f197854826ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.8,
        "y": 0.65
      },
      "kind": "metric",
      "text": "500+ CUSTOMERS",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "292a5be1-ff24-4153-a6ed-3cb53768b008",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.8,
        "y": 0.5
      },
      "kind": "metric",
      "text": "2,200 SERVICES ASSOCIATES",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d436fd33-aa0f-4f27-bb35-351bb8cf0335",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.55,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Avantor's offering supports R&D activities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "762f570a-5fd8-48c1-b202-342b99fda2e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Represents 55% of total Biopharma revenue¹",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6881ffa2-aa00-478d-a833-abaa89bd1273",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "a4c9a289-1625-4d5e-afc0-0325e95ab2d2",
      "evidence": "R&D PROCESS: Understanding mechanism of disease, Drug target & identification, Biopharmaceutical development, Testing in biochemical & cellular models, Animal & first in man studies",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "27aac259-4c07-4a4b-963e-81911b644938",
      "evidence": "R&D process flow diagram",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 89,
      "from": 17,
      "beatId": "2aa3ce3e-d4bb-4cda-b13e-25db1a3054af",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Growth prospects and financial highlights",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 40,
      "from": 21,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "44a7c149-2da8-4925-9541-064336919963",
      "evidence": "Case study and supporting data",
      "position": 0,
      "objective": "Show how Avantor's offering supports Biopharma R&D activities",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}